Skip to main content

Perflubron (PFOB) protects against fatty acid oxidation in a non-biological, in vitro model

Publication ,  Journal Article
Rotta, AT; Gunnarsson, B; Hernan, LJ; Steinhorn, DM
Published in: Critical Care Medicine
January 1, 1999

Introduction: Oxidative stress is one of the basic mechanisms of tissue injury, having been implicated in various processes such as aging, cancer, sepsis, inflammation, as well as cardiovascular and respiratory diseases. In view of the fact that PFOB attenuates oxidative lung injury in vivo, we hypothesized that this finding might be due, in part, to a direct protective effect of PFOB against reactive oxygen species-associated injury Methods: We tested the hypothesis by studying an in vitro non-biological system. Linoleic acid (3mM) was emulsified into an aqueous buffer (PBS) by a detergent (SDS, 250μM). Linoleic acid/SDS micelles were formed by agitation and sonication of the emulsion. Oxidative stress was applied by adding various concentrations (2-50mM) of AAPH, a peroxyl radical generator, to the emulsion in the absence (control) or presence (PFOB) of PFOB at 37°C. Malondialdehyde (MDA) was used as an indicator of oxidation of linoleic acid micelles. MDA concentrations were measured in samples originated from the emulsion over a period of 4 hours. Results: Values are means ± SD for the 20mM AAPH experiment. Experiments with other concentrations of AAPH resulted in similar patterns. *p < 0.05 vs baseline. † p < 0.05 vs PFOB. Conclusions: PFOB attenuates oxidative damage to synthetic linoleic acid micelles from various concentrations of AAPH in a non-biological system. This effect may account for the decreased oxidative damage to injury-prone tissues exposed to PFOB.

Duke Scholars

Published In

Critical Care Medicine

DOI

ISSN

0090-3493

Publication Date

January 1, 1999

Volume

27

Issue

1 SUPPL.

Related Subject Headings

  • Emergency & Critical Care Medicine
  • 1117 Public Health and Health Services
  • 1110 Nursing
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rotta, A. T., Gunnarsson, B., Hernan, L. J., & Steinhorn, D. M. (1999). Perflubron (PFOB) protects against fatty acid oxidation in a non-biological, in vitro model. Critical Care Medicine, 27(1 SUPPL.). https://doi.org/10.1097/00003246-199901001-00371
Rotta, A. T., B. Gunnarsson, L. J. Hernan, and D. M. Steinhorn. “Perflubron (PFOB) protects against fatty acid oxidation in a non-biological, in vitro model.” Critical Care Medicine 27, no. 1 SUPPL. (January 1, 1999). https://doi.org/10.1097/00003246-199901001-00371.
Rotta AT, Gunnarsson B, Hernan LJ, Steinhorn DM. Perflubron (PFOB) protects against fatty acid oxidation in a non-biological, in vitro model. Critical Care Medicine. 1999 Jan 1;27(1 SUPPL.).
Rotta, A. T., et al. “Perflubron (PFOB) protects against fatty acid oxidation in a non-biological, in vitro model.” Critical Care Medicine, vol. 27, no. 1 SUPPL., Jan. 1999. Scopus, doi:10.1097/00003246-199901001-00371.
Rotta AT, Gunnarsson B, Hernan LJ, Steinhorn DM. Perflubron (PFOB) protects against fatty acid oxidation in a non-biological, in vitro model. Critical Care Medicine. 1999 Jan 1;27(1 SUPPL.).

Published In

Critical Care Medicine

DOI

ISSN

0090-3493

Publication Date

January 1, 1999

Volume

27

Issue

1 SUPPL.

Related Subject Headings

  • Emergency & Critical Care Medicine
  • 1117 Public Health and Health Services
  • 1110 Nursing
  • 1103 Clinical Sciences